| DC Field | Value | Language |
|---|
| dc.contributor.author | Skachilova, S. Ya. | - |
| dc.contributor.author | Simakina, E. A. | - |
| dc.contributor.author | Denisenko, A. V. | - |
| dc.contributor.author | Shilova, E. V. | - |
| dc.contributor.author | Motailo, A. L. | - |
| dc.date.accessioned | 2025-11-17T11:41:08Z | - |
| dc.date.available | 2025-11-17T11:41:08Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | A drug as a two-faced Janus: dose-effect, adverse events / Skachilova S.Ya., E.A. Simakina, A.V. Denisenko [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №3.-P. 61-76. - Doi: 10.18413/rrpharmacology.11.561. - Refer.: p. 74-76. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65894 | - |
| dc.description.abstract | In the pharmaceutical industry, the 21st century was marked by the creation of new highly effective drugs: synthetic, immunobiological, genetic engineering, etc. Pharmacotherapy with highly effective drugs leads to a detailed study of their safety and pharmacoepidemiological studies, both in our country and abroad | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | adverse drug reactions | ru |
| dc.subject | safety of pharmacotherapy | ru |
| dc.subject | central nervous system diseases | ru |
| dc.subject | enantiomers | ru |
| dc.subject | antioxidants | ru |
| dc.subject | pharmacovigilance | ru |
| dc.subject | monitoring | ru |
| dc.title | A drug as a two-faced Janus: dose-effect, adverse events | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 3
|
